NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $257,604 | +0.9% | 2,529 | 0.0% | 0.03% | -2.9% |
| Q2 2023 | $255,201 | +24.4% | 2,529 | +13.5% | 0.03% | +13.3% |
| Q1 2023 | $205,068 | +1.4% | 2,229 | 0.0% | 0.03% | -6.2% |
| Q4 2022 | $202,215 | -4.2% | 2,229 | -10.5% | 0.03% | -22.0% |
| Q2 2022 | $211,000 | -3.7% | 2,491 | 0.0% | 0.04% | +5.1% |
| Q1 2022 | $219,000 | +8.4% | 2,491 | +12.4% | 0.04% | -2.5% |
| Q2 2021 | $202,000 | -76.9% | 2,217 | -78.1% | 0.04% | -83.5% |
| Q3 2018 | $873,000 | +15.0% | 10,128 | +0.8% | 0.24% | +3.8% |
| Q2 2018 | $759,000 | -6.8% | 10,044 | -0.2% | 0.23% | -11.0% |
| Q1 2018 | $814,000 | -1.5% | 10,066 | +2.3% | 0.26% | -4.4% |
| Q4 2017 | $826,000 | -0.5% | 9,842 | +1.8% | 0.28% | -7.1% |
| Q3 2017 | $830,000 | +7.4% | 9,665 | +4.4% | 0.30% | +0.7% |
| Q2 2017 | $773,000 | – | 9,258 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |